相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Thresholds for post-rebound SHIV control after CCR5 gene-edited autologous hematopoietic cell transplantation
E. Fabian Cardozo-Ojeda et al.
ELIFE (2021)
Combination gene therapy for HIV using a conditional suicidal gene with CCR5 knockout
Tugba Mehmetoglu-Gurbuz et al.
VIROLOGY JOURNAL (2021)
Automated production of CCR5-negative CD4+-T cells in a GMP-compatible, clinical scale for treatment of HIV-positive patients
Lea Isabell Schwarze et al.
GENE THERAPY (2021)
CCR5-edited CD4+ T cells augment HIV-specific immunity to enable post-rebound control of HIV replication
Pablo Tebas et al.
JOURNAL OF CLINICAL INVESTIGATION (2021)
Optimisation of a TALE nuclease targeting the HIV co-receptor CCR5 for clinical application
Lea Isabell Schwarze et al.
GENE THERAPY (2021)
Modeling of CCR5 Recognition by HIV-1 gp120: How the Viral Protein Exploits the Conformational Plasticity of the Coreceptor
Celien Jacquemard et al.
VIRUSES-BASEL (2021)
Antibody-based CCR5 blockade protects Macaques from mucosal SHIV transmission
Xiao L. Chang et al.
NATURE COMMUNICATIONS (2021)
Structural basis for chemokine recognition and receptor activation of chemokine receptor CCR5
Hui Zhang et al.
NATURE COMMUNICATIONS (2021)
Genetic variation in the chemokine receptor 5 gene and course of HIV infection; review on genetics and immunological aspect
M. K. Verma et al.
GENES & DISEASES (2021)
What we say and what we mean when we say redundancy and robustness of the chemokine system - how CCR5 challenges these concepts
Joel H. Ellwanger et al.
IMMUNOLOGY AND CELL BIOLOGY (2020)
Computational Analysis Concerning the Impact of DNA Accessibility on CRISPR-Cas9 Cleavage Efficiency
Cheng-Han Chung et al.
MOLECULAR THERAPY (2020)
Mapping the extent of heterogeneity of human CCR5+CD4+T cells in peripheral blood and lymph nodes
John Zaunders et al.
AIDS (2020)
No statistical evidence for an effect of CCR5- increment 32 on lifespan in the UK Biobank cohort
Robert Maier et al.
NATURE MEDICINE (2020)
Evidence for HIV-1 cure after CCR5Δ32/Δ32 allogeneic haemopoietic stem-cell transplantation 30 months post analytical treatment interruption: a case report
Ravindra Kumar Gupta et al.
LANCET HIV (2020)
Safe CRISPR-Cas9 Inhibition of HIV-1 with High Specificity and Broad-Spectrum Activity by Targeting LTR NF-κB Binding Sites
Cheng-Han Chung et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2020)
Genome editing of CCR5 by AsCpf1 renders CD4+T cells resistance to HIV-1 infection
Zhepeng Liu et al.
CELL AND BIOSCIENCE (2020)
Antibody-based strategies in HIV therapy
Wesley D. Kufel
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2020)
Immune activation correlates with and predicts CXCR4 co-receptor tropism switch in HIV-1 infection
Bridgette J. Connell et al.
SCIENTIFIC REPORTS (2020)
Applications of genome editing technology in the targeted therapy of human diseases: mechanisms, advances and prospects
Hongyi Li et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)
Penicillixanthone A, a marine-derived dual-coreceptor antagonist as anti-HIV-1 agent
Suiyi Tan et al.
NATURAL PRODUCT RESEARCH (2019)
CCR5/CXCR4 Dual Antagonism for the Improvement of HIV Infection Therapy
Fedora Grande et al.
MOLECULES (2019)
HIV-1 remission following CCR5Δ32/Δ32 haematopoietic stem-cell transplantation
Ravindra K. Gupta et al.
NATURE (2019)
CCR5-Δ32 is deleterious in the homozygous state in humans
Xinzhu Wei et al.
NATURE MEDICINE (2019)
The Ontogeny of Monocyte Subsets
Anja A. Wolf et al.
FRONTIERS IN IMMUNOLOGY (2019)
Cis-regulatory genetic variants in the CCR5 gene and natural HIV-1 control in black South Africans
Gemma W. Koor et al.
CLINICAL IMMUNOLOGY (2019)
CRISPR-Edited Stem Cells in a Patient with HIV and Acute Lymphocytic Leukemia
Lei Xu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Novel gRNA design pipeline to develop broad-spectrum CRISPR/Cas9 gRNAs for safe targeting of the HIV-1 quasispecies in patients
Neil T. Sullivan et al.
SCIENTIFIC REPORTS (2019)
Structural basis of coreceptor recognition by HIV-1 envelope spike
Md Munan Shaik et al.
NATURE (2019)
CCR5 is a required signaling receptor for macrophage expression of inflammatory genes in response to viral double-stranded RNA
Zachary R. Shaheen et al.
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2019)
HIV u Is a cure possible
Murugan Sankaranantham
INDIAN JOURNAL OF SEXUALLY TRANSMITTED DISEASES AND AIDS (2019)
Activity and structural analysis of GRL-117C: a novel small molecule CCR5 inhibitor active against R5-tropic HIV-1s
Hirotomo Nakata et al.
SCIENTIFIC REPORTS (2019)
CCR5- increment 32 is deleterious in the homozygous state in humans
Xinzhu Wei et al.
NATURE MEDICINE (2019)
Efficient ZFN-Mediated Stop Codon Integration into the CCR5 Locus in Hematopoietic Stem Cells: A Possible Source for Intrabone Marrow Cell Transplantation
Supreecha Chattong et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2018)
Broad-Spectrum and Personalized Guide RNAs for CRISPR/Cas9 HIV-1 Therapeutics
Will Dampier et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2018)
A guide to chemokines and their receptors
Catherine E. Hughes et al.
FEBS JOURNAL (2018)
Simultaneous Knockout of CXCR4 and CCR5 Genes in CD4+T Cells via CRISPR/Cas9 Confers Resistance to Both X4-and R5-Tropic Human Immunodeficiency Virus Type 1 Infection
Songlin Yu et al.
HUMAN GENE THERAPY (2018)
Dolutegravir (DTG)-containing regimens after receiving raltegravir (RAL) or elvitegravir (EVG): Durability and virological response in a large Italian HIV drug resistance network (ARCA)
S. Rusconi et al.
JOURNAL OF CLINICAL VIROLOGY (2018)
Analysis and dissociation of anti-HIV effects of shRNA to CCR5 and the fusion inhibitor C46
Scott Ledger et al.
JOURNAL OF GENE MEDICINE (2018)
Mapping Interaction Sites on Human Chemokine Receptors by Deep Mutational Scanning
Jeremiah D. Heredia et al.
JOURNAL OF IMMUNOLOGY (2018)
The evolution of HIV-1 entry phenotypes as a guide to changing target cells
Sarah B. Joseph et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2018)
The return of PRO 140, a CCR5-directed mAb
Melanie A. Thompson
CURRENT OPINION IN HIV AND AIDS (2018)
InducingCCR5Δ32/Δ32 Homozygotes in the Human Jurkat CD4+Cell Line and Primary CD4+Cells by CRISPR-Cas9 Genome-Editing Technology
Chunxia Qi et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2018)
Optimization of Polycistronic Anti-CCR5 Artificial microRNA Leads to Improved Accuracy of Its Lentiviral Vector Transfer and More Potent Inhibition of HIV-1 in CD4+ T-Cells
Felix Urusov et al.
CELLS (2018)
Gene Editing of HIV-1 Co-receptors to Prevent and/or Cure Virus Infection
Alexander G. Allen et al.
FRONTIERS IN MICROBIOLOGY (2018)
Current challenges in the treatment of HIV
Lucie Seyler et al.
POLISH ARCHIVES OF INTERNAL MEDICINE-POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ (2018)
Frequencies of gene variant CCR5-Δ32 in 87 countries based on next-generation sequencing of 1.3 million individuals sampled from 3 national DKMS donor centers
Ute V. Solloch et al.
HUMAN IMMUNOLOGY (2017)
Transcriptional Reprogramming during Effector-to-Memory Transition Renders CD4+ T Cells Permissive for Latent HIV-1 Infection
Liang Shan et al.
IMMUNITY (2017)
CRISPR/Cas9-Mediated CCR5 Ablation in Human Hematopoietic Stem/Progenitor Cells Confers HIV-1 Resistance In Vivo
Lei Xu et al.
MOLECULAR THERAPY (2017)
Novel AgoshRNA molecules for silencing of the CCR5 co-receptor for HIV-1 infection
Elena Herrera-Carrillo et al.
PLOS ONE (2017)
The Role of Natural Antibodies to CC Chemokine Receptor 5 in HIV infection
Assunta Venuti et al.
FRONTIERS IN IMMUNOLOGY (2017)
CCR5 promoter activity correlates with HIV disease progression by regulating CCR5 cell surface expression and CD4 T cell apoptosis
Anjali Joshi et al.
SCIENTIFIC REPORTS (2017)
Designing broad-spectrum anti-HIV-1 gRNAs to target patient-derived variants
Will Dampier et al.
SCIENTIFIC REPORTS (2017)
Haplotypes in CCR5-CCR2, CCL3 and CCL5 are associated with natural resistance to HIV-1 infection in a Colombian cohort
Jorge A. Vega et al.
BIOMEDICA (2017)
cAMP Signaling Enhances HIV-1 Long Terminal Repeat (LTR)-directed Transcription and Viral Replication in Bone Marrow Progenitor Cells
Anupam Banerjee et al.
CLINICAL MEDICINE INSIGHTS- PATHOLOGY (2017)
Functional Studies of CCAAT/Enhancer Binding Protein Site Located Downstream of the Transcriptional Start Site
Yujie Liu et al.
CLINICAL MEDICINE INSIGHTS- PATHOLOGY (2017)
Stem cell-based therapies for HIV/AIDS
Olivier Pernet et al.
ADVANCED DRUG DELIVERY REVIEWS (2016)
Optimized sgRNA design to maximize activity and minimize off-target effects of CRISPR-Cas9
John G. Doench et al.
NATURE BIOTECHNOLOGY (2016)
Utilization of HIV-1 envelope V3 to identify X4-and R5-specific Tat and LTR sequence signatures
Gregory C. Antell et al.
RETROVIROLOGY (2016)
HIV coreceptor tropism determination and mutational pattern identification
Hui-Shuang Shen et al.
SCIENTIFIC REPORTS (2016)
Effects of Combined CCR5/Integrase Inhibitors-Based Regimen on Mucosal Immunity in HIV-Infected Patients Naive to Antiretroviral Therapy: A Pilot Randomized Trial (vol 12, e1005381, 2016)
Sergio Serrano-Villar et al.
PLOS ONE (2016)
Inhibition of HIV-1 entry by the tricyclic coumarin GUT-70 through the modification of membrane fluidity
Kouki Matsuda et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2015)
Inhibition of HIV-1 infection of primary CD4(+) T-cells by gene editing of CCR5 using adenovirus-delivered CRISPR/Cas9
Chang Li et al.
JOURNAL OF GENERAL VIROLOGY (2015)
P2X1 Receptor Antagonists Inhibit HIV-1 Fusion by Blocking Virus-Coreceptor Interactions
Charline Giroud et al.
JOURNAL OF VIROLOGY (2015)
Lentivector Knockdown of CCR5 in Hematopoietic Stem and Progenitor Cells Confers Functional and Persistent HIV-1 Resistance in Humanized Mice
Renier Myburgh et al.
JOURNAL OF VIROLOGY (2015)
Pyrazolo-Piperidines Exhibit Dual Inhibition of CCR5/CXCR4 HIV Entry and Reverse Transcriptase
Bryan D. Cox et al.
ACS MEDICINAL CHEMISTRY LETTERS (2015)
HIV-1 CCR5 gene therapy will fail unless it is combined with a suicide gene
Aridaman Pandit et al.
SCIENTIFIC REPORTS (2015)
CCR5 Disruption in Induced Pluripotent Stem Cells Using CRISPR/Cas9 Provides Selective Resistance of Immune Cells to CCR5-tropic HIV-1 Virus
HyunJun Kang et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2015)
CCR5 knockout mice with C57BL6 background are resistant to acetaminophen-mediated hepatotoxicity due to decreased macrophages migration into the liver
Dong-Young Choi et al.
ARCHIVES OF TOXICOLOGY (2015)
Generation of CCR5-defective CD34 cells from ZFN-driven stop codon-integrated mesenchymal stem cell clones
Krissanapong Manotham et al.
JOURNAL OF BIOMEDICAL SCIENCE (2015)
The number of CCR5 expressing CD4+T lymphocytes is lower in HIV-infected long-term non-progressors with viral control compared to normal progressors: a cross-sectional study
Hinta Meijerink et al.
BMC INFECTIOUS DISEASES (2014)
Structure prediction of GPCRs using piecewise homologs and application to the human CCR5 chemokine receptor: validation through agonist and antagonist docking
Karthik Arumugam et al.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2014)
Gene Editing of CCR5 in Autologous CD4 T Cells of Persons Infected with HIV
Pablo Tebas et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Molecular Recognition of CCR5 by an HIV-1 gp120 V3 Loop
Phanourios Tamamis et al.
PLOS ONE (2014)
Dual Role of Novel Ingenol Derivatives from Euphorbia tirucalli in HIV Replication: Inhibition of De Novo Infection and Activation of Viral LTR
Celina M. Abreu et al.
PLOS ONE (2014)
Defining Differential Genetic Signatures in CXCR4-and the CCR5-Utilizing HIV-1 Co-Linear Sequences
Benjamas Aiamkitsumrit et al.
PLOS ONE (2014)
Functional properties of the HIV-1 long terminal repeat containing single-nucleotide polymorphisms in Sp site III and CCAAT/enhancer binding protein site I
Sonia Shah et al.
VIROLOGY JOURNAL (2014)
CCR5 Gene Editing of Resting CD4+ T Cells by Transient ZFN Expression From HIV Envelope Pseudotyped Nonintegrating Lentivirus Confers HIV-1 Resistance in Humanized Mice
Guohua Yi et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2014)
Preclinical safety and efficacy of an anti-HIV-1 lentiviral vector containing a short hairpin RNA to CCR5 and the C46 fusion inhibitor
Orit Wolstein et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2014)
Inhibition of HIV-1 replication by a tricyclic coumarin GUT-70 in acutely and chronically infected cells
Eriko Kudo et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2013)
The immunologic effects of maraviroc intensification in treated HIV-infected individuals with incomplete CD4+ T-cell recovery: a randomized trial
Peter W. Hunt et al.
BLOOD (2013)
DNA targeting specificity of RNA-guided Cas9 nucleases
Patrick D. Hsu et al.
NATURE BIOTECHNOLOGY (2013)
Targeted genome engineering in human cells with the Cas9 RNA-guided endonuclease
Seung Woo Cho et al.
NATURE BIOTECHNOLOGY (2013)
Differential integrity of TALE nuclease genes following adenoviral and lentiviral vector gene transfer into human cells
Maarten Holkers et al.
NUCLEIC ACIDS RESEARCH (2013)
HIV-1 ENV gp120 structural determinants for peptide triazole dual receptor site antagonism
Ferit Tuzer et al.
PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS (2013)
Cellular and molecular mechanisms involved in the establishment of HIV-1 latency
Daniel A. Donahue et al.
RETROVIROLOGY (2013)
Multiplex Genome Engineering Using CRISPR/Cas Systems
Le Cong et al.
SCIENCE (2013)
Vicriviroc plus optimized background therapy for treatment-experienced subjects with CCR5 HIV-1 infection: Final results of two randomized phase III trials
Marcos M. Caseiro et al.
JOURNAL OF INFECTION (2012)
High CCR5 Density on Central Memory CD4+ T Cells in Acute HIV-1 Infection Is Mostly Associated with Rapid Disease Progression
Xue Yang et al.
PLOS ONE (2012)
The Crystal Structure of TAL Effector PthXo1 Bound to Its DNA Target
Amanda Nga-Sze Mak et al.
SCIENCE (2012)
Structural Basis for Sequence-Specific Recognition of DNA by TAL Effectors
Dong Deng et al.
SCIENCE (2012)
Ccr5 deficiency regulates the proliferation and trafficking of natural killer cells under physiological conditions
Ido D. Weiss et al.
CYTOKINE (2011)
Natural anti-CCR5 antibodies in HIV-infection and -exposure
Lucia Lopalco
JOURNAL OF TRANSLATIONAL MEDICINE (2011)
Generation of HIV-1 Resistant and Functional Macrophages From Hematopoietic Stem Cell-derived Induced Pluripotent Stem Cells
Amal Kambal et al.
MOLECULAR THERAPY (2011)
HIV Latency
Robert F. Siliciano et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2011)
Phase 2a Study of the CCR5 Monoclonal Antibody PRO 140 Administered Intravenously to HIV-Infected Adults
Jeffrey M. Jacobson et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Anti-HIV-1 Activity of Weekly or Biweekly Treatment with Subcutaneous PRO 140, a CCR5 Monoclonal Antibody
Jeffrey M. Jacobson et al.
JOURNAL OF INFECTIOUS DISEASES (2010)
Vicriviroc in Combination Therapy with an Optimized Regimen for Treatment-Experienced Subjects: 48-Week Results of the VICTOR-E1 Phase 2 Trial
Jamal Suleiman et al.
JOURNAL OF INFECTIOUS DISEASES (2010)
Human hematopoietic stem/progenitor cells modified by zinc-finger nucleases targeted to CCR5 control HIV-1 in vivo
Nathalia Holt et al.
NATURE BIOTECHNOLOGY (2010)
HIV-1 infects multipotent progenitor cells causing cell death and establishing latent cellular reservoirs
Christoph C. Carter et al.
NATURE MEDICINE (2010)
The discovery of zinc fingers and their development for practical applications in gene regulation and genome manipulation
Aaron Klug
QUARTERLY REVIEWS OF BIOPHYSICS (2010)
CCR5: From Natural Resistance to a New Anti-HIV Strategy
Lucia Lopalco
VIRUSES-BASEL (2010)
Blood Monocytes: Development, Heterogeneity, and Relationship with Dendritic Cells
Cedric Auffray et al.
ANNUAL REVIEW OF IMMUNOLOGY (2009)
Pattern and Temporal Sequence of Sulfation of CCR5 N-Terminal Peptides by Tyrosylprotein Sulfotransferase-2: An Assessment of the Effects of N-Terminal Residues
Connie H. Jen et al.
BIOCHEMISTRY (2009)
Chemokines and chemokine receptors: an overview
Raffaella Bonecchi et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2009)
Relationship Between HIV Coreceptor Tropism and Disease Progression in Persons With Untreated Chronic HIV Infection
Matthew Bidwell Goetz et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2009)
CCR5 Expression Levels Influence NFAT Translocation, IL-2 Production, and Subsequent Signaling Events during T Lymphocyte Activation
Jose F. Camargo et al.
JOURNAL OF IMMUNOLOGY (2009)
Long-Term Control of HIV by CCR5 Delta32/Delta32 Stem-Cell Transplantaion
Gero Huetter et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Genetic determinants of HIV-1 infection and progression to AIDS: immune response genes
G. Kaur et al.
TISSUE ANTIGENS (2009)
How HIV changes its tropism: evolution and adaptation?
Donald E. Mosier
CURRENT OPINION IN HIV AND AIDS (2009)
The biology of CCR5 and CXCR4
Ghalib Alkhatib
CURRENT OPINION IN HIV AND AIDS (2009)
CC chemokine receptor 5 gene promoter activation by the cyclic AMP response element binding transcription factor
Hedwich F. Kuipers et al.
BLOOD (2008)
The impact of HIV tropism on decreases in CD4 cell count, clinical progression, and subsequent response to a first antiretroviral therapy regimen
Laura Waters et al.
CLINICAL INFECTIOUS DISEASES (2008)
Cellular Reservoirs of HIV-1 and their Role in Viral Persistence
Aikaterini Alexaki et al.
CURRENT HIV RESEARCH (2008)
The chemokine receptor CCR5 plays a key role in the early memory CD8+ T cell response to respiratory virus infections
Jacob E. Kohlmeier et al.
IMMUNITY (2008)
Establishment of HIV-1 resistance in CD4+ T cells by genome editing using zinc-finger nucleases
Elena E. Perez et al.
NATURE BIOTECHNOLOGY (2008)
Reduction of CCR5 with low-dose rapamycin enhances the antiviral activity of vicriviroc against both sensitive and drug-resistant HIV-1
Alonso Heredia et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
HIV-1 Infection of Bone Marrow Hematopoietic Progenitor Cells and Their Role in Trafficking and Viral Dissemination
Aikaterini Alexaki et al.
PLOS PATHOGENS (2008)
Phase 2 study of the safety and efficacy of vicriviroc, a CCR5 inhibitor, in HIV-1-infected, treatment experienced patients: AIDS clinical trials group 5211
Roy M. Gulick et al.
JOURNAL OF INFECTIOUS DISEASES (2007)
Recognition of RANTES by extracellular parts of the CCR5 receptor
Luminita Duma et al.
JOURNAL OF MOLECULAR BIOLOGY (2007)
CCR5 expression and duration of high risk sexual activity among HIV-seronegative men who have sex with men
Susan M. Thomas et al.
AIDS (2006)
CCR5 is essential for NK cell trafficking and host survival following Toxoplasma gondii infection
Imtiaz A. Khan et al.
PLOS PATHOGENS (2006)
CCL5-CCR5 interaction provides antiapoptotic signals for macrophage survival during viral infection
JW Tyner et al.
NATURE MEDICINE (2005)
Combined effect of CCR5-Δ32 heterozygosity and the CCR5 promoter polymorphism-2459 A/G on CCR5 expression and resistance to human immunodeficiency virus type 1 transmission
F Hladik et al.
JOURNAL OF VIROLOGY (2005)
Opposing effects of CXCR3 and CCR5 deficiency on CD8+ T cell-mediated inflammation in the central nervous system of virus-infected mice
C de Lemos et al.
JOURNAL OF IMMUNOLOGY (2005)
Role of Rho family GTPases in CCR1- and CCR5-induced actin reorganization in macrophages
P Di Marzio et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2005)
Association of CCR5 human haplogroup E with rapid HIV type 1 disease progression
M Li et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2005)
Inhibition of leukemic cell growth by a novel anti-cancer drug (GUT-70) from Calophyllum brasiliense that acts by induction of apoptosis
S Kimura et al.
INTERNATIONAL JOURNAL OF CANCER (2005)
High-affinity interaction between HIV-1 Vpr and specific sequences that span the C/EBP and adjacent NF-κB sites within the HIV-1 LTR correlate with HIV-1-associated dementia
TH Burdo et al.
DNA AND CELL BIOLOGY (2004)
Mobilization of dendritic cell precursors into the circulation by administration of MIP-1α in mice
YY Zhang et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2004)
Chemokine receptor expression in B-cell lymphoproliferative disorders
SWJ Wong et al.
LEUKEMIA & LYMPHOMA (2004)
Inhibition of human immunodeficiency virus replication by a dual CCR5/CXCR4 antagonist
K Princen et al.
JOURNAL OF VIROLOGY (2004)
Genetic influence of CCR5, CCR2, and SDF1 variants on human immunodeficiency virus 1 (HIV-1)-related disease progression and neurological impairment, in children with symptomatic HIV-1 infection
KK Singh et al.
JOURNAL OF INFECTIOUS DISEASES (2003)
CC chemokine receptor 5 genotype and susceptibility to transmission of human immunodeficiency virus type 1 in women
S Philpott et al.
JOURNAL OF INFECTIOUS DISEASES (2003)
MIP-1α and MIP-1β differentially mediate mucosal and systemic adaptive immunity
JW Lillard et al.
BLOOD (2003)
Structural and functional evolution of human immunodeficiency virus type 1 long terminal repeat CCAAT/enhancer binding protein sites and their use as molecular markers for central nervous system disease progression
TH Hogan et al.
JOURNAL OF NEUROVIROLOGY (2003)
Structure modeling of the chemokine receptor CCR5: Implications for ligand binding and selectivity
MG Paterlini
BIOPHYSICAL JOURNAL (2002)
Regulation of human immunodeficiency virus type 1 gene expression and pathogenesis by CCAAT/enhancer binding proteins in cells of the monocyte/macrophage lineage
TH Hogan et al.
JOURNAL OF NEUROVIROLOGY (2002)
Cell surface CCR5 density determines the postentry efficiency of R5 HIV-1 infection
YL Lin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Cholesterol is essential for macrophage inflammatory protein 1β binding and conformational integrity of CC chemokine receptor 5
DH Nguyen et al.
BLOOD (2002)
The role of CC chemokine receptor 5 in antiviral immunity
A Nansen et al.
BLOOD (2002)
Up-regulation of CCR5 and CCR6 on distinct subpopulations of antigen-activated CD4(+) T lymphocytes
LM Ebert et al.
JOURNAL OF IMMUNOLOGY (2002)
Functional expression of the chemokine receptor CCR5 on virus epitope-specific memory and effector CD8(+) T cells
K Fukada et al.
JOURNAL OF IMMUNOLOGY (2002)
A membrane-proximal basic domain and cysteine cluster in the C-terminal tail of CCR5 constitute a bipartite motif critical for cell surface expression
S Venkatesan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Desensitization of chemokine receptor CCR5 in dendritic cells at the early stage of differentiation by activation of formyl peptide receptors
YY Le et al.
CLINICAL IMMUNOLOGY (2001)
Generation of HIV latency during thymopoiesis
DG Brooks et al.
NATURE MEDICINE (2001)
Interaction between CCAAT/enhancer binding protein and cyclic AMP response element binding protein 1 regulates human immunodeficiency virus type 1 transcription in cells of the monocyte/macrophage lineage
HL Ross et al.
JOURNAL OF VIROLOGY (2001)
Endocytosis and recycling of the HIV coreceptor CCR5
N Signoret et al.
JOURNAL OF CELL BIOLOGY (2000)
Combination of CCR5 and CXCR4 inhibitors in therapy of human immunodeficiency virus type 1 infection: In vitro studies of mixed virus infections
S Rusconi et al.
JOURNAL OF VIROLOGY (2000)
CCR5 provides a signal for microbial induced production of IL-12 by CD8α+ dendritic cells
J Aliberti et al.
NATURE IMMUNOLOGY (2000)
CCR5-reactive antibodies in seronegative partners of HIV-seropositive individuals down-modulate surface CCR5 in vivo and neutralize the infectivity of R5 strains of HIV-1 in vitro
L Lopalco et al.
JOURNAL OF IMMUNOLOGY (2000)
Analysis of the HIV-1 LTR NF-kappa B-proximal Sp site III: Evidence for cell type-specific gene regulation and viral replication
JJ McAllister et al.
VIROLOGY (2000)
The suramin analogue NF279 is a novel and potent antagonist selective for the P2X(1) receptor
J Rettinger et al.
NEUROPHARMACOLOGY (2000)
分享论文
